Breast cancer and mRNA COVID-19 vaccinations

I appreciate you sharing this context, but I notice the patient information and specific question appear to be incomplete or cut off in your message. I can see:

• Patient context: Breast cancer diagnosis, recent Kisqali (ribociclib) treatment cycles, concerns about white blood cell counts
• Languages detected: English and Greek
• Topic area: [ID removed] COVID-19 vaccinations and breast cancer

However, I'm missing:

• The complete patient question you'd like me to address
• Attached medical documents (the context shows "[ATTACHED DOCUMENT CON..." but the file didn't come through)
• Specific concerns about the vaccination topic

---

How I can help once you clarify:

If your question is about [ID removed] COVID-19 vaccination safety during breast cancer treatment, I can:

✅ Explain what current oncology guidelines say about vaccination during chemotherapy/targeted therapy
✅ Discuss immune response considerations with CDK4/6 inhibitors like Kisqali
✅ Help you prepare questions for your oncology team about timing and safety
✅ Interpret any immune markers from your blood work

---

Please help me by:

1. Reposting your complete question in English (I can work with Greek too, but clearer if you choose one language)
2. Re-uploading any medical documents you wanted me to review
3. Clarifying what specifically concerns you — for example:
   • Is it safe to get vaccinated during Kisqali treatment?
   • Should I delay vaccination until after treatment?
   • Are there specific side effects to watch for?

Once I have the full picture, I'll give you evidence-based information grounded in NCCN Guidelines and ASCO recommendations for your situation.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.